Base to Base biotech podcast 50: Drugs for kidney transplants, glycans, and  drug delivery
Anti-cancer drug gets phase I FDA trials approval
New mass spec platform launched
Approval for prostate cancer treatment
Base to Base biotech podcast 3: Nanoparticles and Duchenne muscular dystrophy
Canadian university researchers discover new class of antibiotics
Base to Base biotech podcast 2: Opioid alternatives and epiproteomics
Base to Base biotech podcast 1: Osteoboost and Pheast Therapeutics
SXSW announces 2025 pitch competition finalists
LinkGevity secures place in SPACE-H accelerator programme
LinkGevity awarded deeptech EU grant
Healthy AI: sustainable artificial intelligence for healthcare